Difference between revisions of "DZI20-66-Case-2"

From MGH Learn Pathology
(Updating subject, access, and performer)
(Added status template)
 
Line 29: Line 29:
 
|subject=Z0FBQUFBQmYyakw2NEdtaGtlZkpIUGNiNUhRd0FFSk5obnJxM1o3UkNveFp6UVVKVWNNZUFYekJLRV9pcGkzSlhZUDJ4c2hvcnZTWDNaT1VRNjNtdlFja1JkemJmaE1zdGlFXzB2YlNDYTNiMy14TEt2Tm1PUGc9
 
|subject=Z0FBQUFBQmYyakw2NEdtaGtlZkpIUGNiNUhRd0FFSk5obnJxM1o3UkNveFp6UVVKVWNNZUFYekJLRV9pcGkzSlhZUDJ4c2hvcnZTWDNaT1VRNjNtdlFja1JkemJmaE1zdGlFXzB2YlNDYTNiMy14TEt2Tm1PUGc9
 
|modality=mrxs
 
|modality=mrxs
 +
}}
 +
{{status
 +
|status=active
 +
|requester=Aja51
 +
|authoredOn=December 16, 2020 04:16:35 PM
 
}}
 
}}

Latest revision as of 14:04, December 9, 2024

DZI20-66-Case-2
Lymphopenia, elevated LDH, transaminitis. Diffuse lymphadenopathy, abnormal labs (lymphopenia, rising alkaline phosphatase), symptoms are concerning for malignancy.
Check back soon
December 31, 1969 7:00:00 PM